R&D Partner Content Just launched! The Inaugural ADC Payload Summit - Boston, MA Join 60+ peers to make the biggest impact on your ADCs efficacy through your payload R&D
R&D Partner Content 2nd Gene Therapy Potency Assay Summit Returns to Boston! Effectively Measure Potency to Ensure Reproducible Results For Your Gene Therapy
R&D Partner Content 3rd Process Development for Cell Therapies Summit In the dynamic cell therapy landscape, where financial challenges continue to prevail, the emphasis on innovative process development becomes pivotal.
R&D Partner Content GLP-1-Based Therapeutics Summit Advancing Specialized, Durable, & Efficacious GLP-1s & Investigating Commercial Opportunity to Crystallize Pipeline Strategy & Indication Expansion
R&D Partner Content Cell & Gene Therapy Pricing & Reimbursement Summit Unlocking Patient Access to Affordable Advanced Therapies
News Scribe raises $155m in IPO, as Apnimed pitches for $150m Gene-editing specialist Scribe becomes the 14th biotech to list on the Nasdaq this year, as sleep apnoea drug developer Apnimed prices its listing.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.